Upstream Non Current Assets Total vs Accounts Payable Analysis
| UPB Stock | 19.19 0.26 1.34% |
Upstream Bio, financial indicator trend analysis is much more than just breaking down Upstream Bio, prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Upstream Bio, is a good investment. Please check the relationship between Upstream Bio, Non Current Assets Total and its Accounts Payable accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Upstream Bio,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.
Non Current Assets Total vs Accounts Payable
Non Current Assets Total vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Upstream Bio, Non Current Assets Total account and Accounts Payable. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Upstream Bio,'s Non Current Assets Total and Accounts Payable is 0.95. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Upstream Bio,, assuming nothing else is changed. The correlation between historical values of Upstream Bio,'s Non Current Assets Total and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Upstream Bio, are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Non Current Assets Total i.e., Upstream Bio,'s Non Current Assets Total and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.95 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Accounts Payable
An accounting item on the balance sheet that represents Upstream Bio, obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Upstream Bio, are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from Upstream Bio,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Upstream Bio, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Upstream Bio,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.As of December 28, 2024, Selling General Administrative is expected to decline to about 9.4 M. In addition to that, Issuance Of Capital Stock is expected to decline to about 76.7 M
| 2010 | 2023 | 2024 (projected) | Interest Income | 205K | 4.2M | 2.4M | Net Interest Income | 205K | 4.2M | 2.4M |
Upstream Bio, fundamental ratios Correlations
Click cells to compare fundamentals
Upstream Bio, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Upstream Bio, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Upstream Bio,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Upstream Bio, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Upstream Bio, Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Upstream Bio,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Upstream Bio,. If investors know Upstream will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Upstream Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Upstream Bio, is measured differently than its book value, which is the value of Upstream that is recorded on the company's balance sheet. Investors also form their own opinion of Upstream Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Upstream Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Upstream Bio,'s market value can be influenced by many factors that don't directly affect Upstream Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Upstream Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Upstream Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Upstream Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.